We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
MAAT.PA

Price
6.18
Stock movement up
+- (%)
Company name
Maat Pharma SA
Exchange
(PA
,
Currency
EUR
)
Sector
Healthcare >
Biotechnology
Market cap
85.84M
Ent value
80.00M
Price/Sales
25.02
Price/Book
3.35
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
29.83%
1 year return
-29.29%
3 year return
-20.82%
5 year return
-
10 year return
-
Last updated: 2025-04-17

DIVIDENDS

MAAT.PA does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales25.02
Price to Book3.35
EV to Sales23.31

FINANCIALS

Per share

Per share data
Current share count13.89M
EPS (TTM)-1.98
FCF per share (TTM)-1.78

Income statement

Income statement data
Revenue (TTM)3.43M
Gross profit (TTM)2.30M
Operating income (TTM)-24.16M
Net income (TTM)-24.14M
EPS (TTM)-1.98
EPS (1y forward)-1.19

Margins

Margins data
Gross margin (TTM)67.04%
Operating margin (TTM)-704.20%
Profit margin (TTM)-703.42%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash31.15M
Net receivables6.66M
Total current assets40.65M
Goodwill0.00
Intangible assets1.32M
Property, plant and equipment0.00
Total assets50.92M
Accounts payable5.70M
Short/Current long term debt17.17M
Total current liabilities14.72M
Total liabilities25.31M
Shareholder's equity25.61M
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-18.20M
Capital expenditures (TTM)740.00K
Free cash flow (TTM)-21.68M
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity-94.25%
Return on Assets-47.40%
Return on Invested Capital-73.78%
Cash Return on Invested Capital-66.28%

STOCK INFORMATION

Stock chart

Stock price data
Open6.22
Daily high6.30
Daily low5.94
Daily Volume8K
All-time high13.80
1y analyst estimate16.70
Beta0.19
EPS (TTM)-1.98
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Downside potential data
MAAT.PAS&P500
Current price drop from All-time high-55.22%-14.24%
Highest price drop-64.35%-56.47%
Date of highest drop2 Oct 20239 Mar 2009
Avg drop from high-36.28%-11.07%
Avg time to new high442 days12 days
Max time to new high881 days1805 days
COMPANY DETAILS
MAAT.PA (Maat Pharma SA) company logo
Marketcap
85.84M
Marketcap category
Small-cap
Description
MaaT Pharma SA, a clinical stage company, engages in the research and development of microbiome biotherapies for the treatment of solid cancer tumors. Its products pipeline includes MaaT013 that has completed phase 2 clinical trials for the treatment of acute graft versus host diseases, as well as in preclinical trials to treat melanoma; MaaT033, which is in phase 1b clinical trials for the improvement of survival in patients with acute myeloid leukemia or other liquid tumors receiving allogeneic hematopoietic stem cell transplantation; and MaaT03X for the treatment of solid tumors. The company was incorporated in 2014 and is headquartered in Lyon, France.
Employees
54
Website
https://www.maatpharma.com
Investor relations
-
SEC filings
MAAT.PA SEC filings
CEO
Country
France
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
No events found
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved